Technology in Vaccine Trials

Go back to Blog

In the wake of the COVID-19 pandemic, the world has witnessed both the devastating impact of infectious diseases and the remarkable speed at which vaccines can be developed and deployed. This unprecedented crisis has underscored the need for rapid vaccine clinical trials, driven by a combination of factors: maximizing public benefits, ensuring cost-effective clinical development, and securing a competitive edge in the pharmaceutical industry.

Download Go back to Blog

Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma

Go back to Newsroom

Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma

Strategic hire underscores Emmes Group’s growth and commitment to biopharma market

Emmes Group®, a leading specialty tech and AI-enabled global contract research organization (CRO), today announced the appointment of Germaine Gross to the role of Chief Commercial Officer, Emmes® Biopharma. This strategic hire underscores the company’s commitment to expanding its biopharma footprint, fostering innovation, and redefining excellence in the CRO industry.

Download Go back to Newsroom

Newsroom

The Emmes Group Newsroom features updates on the work we’re doing to advance clinical research and public health. Here you’ll find news about partnerships, contract awards, technology innovations, leadership appointments, industry recognition, and expert perspectives.

Our History

Who We Are

At Emmes Group, our work is driven by a simple but profound belief: truth matters. Since our founding in 1977, we’ve been committed to uncovering truth in clinical research - through scientific rigor, operational excellence, and deep collaboration with our clients and partners.

Emmes Group by the Numbers

At Emmes Group, numbers tell a story of lasting impact. For nearly five decades, we’ve supported the world’s most complex clinical trials with scientific rigor, global reach, and cutting-edge technology. Our key metrics reflect not only the scale of our operations, but also the trust placed in us by leading sponsors, government agencies, and researchers around the world. These numbers are more than stats—they represent our commitment to uncovering the truth behind medical innovation.

Biostats and Analysis Agent

The Veridix Biostats and Analysis Agent empowers biostatistics teams to deliver faster, cleaner, and more consistent outputs across the trial lifecycle. By automating TFL shell creation, interim analyses, and final reports, the agent eliminates repetitive formatting and QC tasks, reduces handoffs between teams, and accelerates time to insight. Built for scale, it brings greater efficiency and control to everything from DSMB packages to CSR-ready outputs - without disrupting your existing workflows.

Veridix

veridix home

Technology and AI Platform

Providing the Technology, Data, Analytical and AI capabilities to modernize and automate clinical research within Emmes and across the industry​.

Making effective use of the compl

Clinical Trial Management

As your clinical trial and site management partner, we go to great lengths to support your sites and their patients.

We provide a variety of tools and support mechanisms to prepare for trial success. Our Clinical Trial Manager is responsible for ensuring sites are set up for success and fostering a relationship which starts at site feasibility and builds through activation, maintenance, and closure.

Pharmacovigilance and Medical Monitoring

To deliver life-changing medical advancements, the clinical research you put into global drug development requires dedicated and detailed management of clinical trial safety risks and high quality of medical monitoring.

As your partner in enabling patient safety and managing enrolled patients safely through the duration of your study, we can provide a forward-thinking approach and a coherent safety data plan.

Then, biostatistics services collaborates with you and clinical tri

Subscribe to